These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 1698231)
21. [The clinical usefulness of urinary determinations of cytokeratin 19 fragment (CYFRA 21-1) in urothelial tumor]. Takeuchi S; Saitoh H; Yoshida K; Satake I; Tari K Hinyokika Kiyo; 1995 Aug; 41(8):589-92. PubMed ID: 7572437 [TBL] [Abstract][Full Text] [Related]
22. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors. Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932 [TBL] [Abstract][Full Text] [Related]
24. Prognosis of genito-urinary malignancies. Cos LR; Caldamone AA; Frank IN AUAA J; 1982; 3(1):4-8. PubMed ID: 6226266 [No Abstract] [Full Text] [Related]
25. [Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer--screening for urothelial cancer in patients with microscopic hematuria. NMP Study Group]. Akaza H; Miyanaga N; Tsukamoto T; Ishikawa S; Noguchi R; Ohtani M; Kawabe K; Kubota Y; Fujita K; Obata K; Hirao Y; Kotake T; Ohmori H; Kumazawa J; Koiso K Gan To Kagaku Ryoho; 1997 May; 24(7):837-42. PubMed ID: 9170522 [TBL] [Abstract][Full Text] [Related]
26. [Carcinomas of the upper urinary tract. With early diagnosis 80-100% of patients survive 5 years]. Hungerhuber E MMW Fortschr Med; 2003 Jan; 145(5):32-5. PubMed ID: 12619206 [TBL] [Abstract][Full Text] [Related]
27. [Urinary cytology. Possibilities, limitations and the future]. Zaak D; Tritschler S; Knuechel R; Vom Dorp F; Hakenberg OW; Hautmann S; Rübben H Urologe A; 2006 Sep; 45 Suppl 4():97-101. PubMed ID: 16821054 [TBL] [Abstract][Full Text] [Related]
28. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma]. Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079 [TBL] [Abstract][Full Text] [Related]
29. Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation. Ho KJ; Kuo SH Cancer; 1995 Aug; 76(3):473-8. PubMed ID: 8625129 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of semaphorin 3A in patients with urothelial cancer. Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007 [TBL] [Abstract][Full Text] [Related]
32. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Gupta R; Paner GP; Amin MB Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765 [TBL] [Abstract][Full Text] [Related]
33. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications. Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924 [TBL] [Abstract][Full Text] [Related]
34. [Novel NMP22 quick qualitative analysis (BladderChek NMP22) for the diagnosis of urothelial tumor]. Minagawa T; Nishizawa S; Kamigaito T; Okaneya T Nihon Hinyokika Gakkai Zasshi; 2006 Jan; 97(1):20-6. PubMed ID: 16485550 [TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors. Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289 [TBL] [Abstract][Full Text] [Related]
36. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Rouprêt M; Yates DR; Comperat E; Cussenot O Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695 [TBL] [Abstract][Full Text] [Related]
37. Clinical study of urine NMP 22 (nuclear matrix protein 22) as a tumor marker in urinary epithelial cancer. Takeuchi Y; Sawada Y; Yabuki D; Masuda E; Satou D; Kuroda K; Tajima M; Sawamura Y; Matsushima M Aktuelle Urol; 2003 Jul; 34(4):265-6. PubMed ID: 14566681 [TBL] [Abstract][Full Text] [Related]
38. Urothelial carcinoma of the bladder and the upper tract: disparate twins. Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150 [TBL] [Abstract][Full Text] [Related]
39. Tumor M2 pyruvate kinase in plasma of patients with urological tumors. Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA Tumour Biol; 2001; 22(5):282-5. PubMed ID: 11553857 [TBL] [Abstract][Full Text] [Related]
40. [A case of urothelial tumors which occurred simultaneously in bilateral upper urinary tracts and bladder presenting with anuria]. Uemura M; Inoue H; Nishimura K; Mizutani S; Miyoshi S; Ota H Hinyokika Kiyo; 2001 Apr; 47(4):269-71. PubMed ID: 11411103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]